Recent Investment Analysts’ Ratings Updates for CME Group (CME)

Several analysts have recently updated their ratings and price targets for CME Group (NASDAQ: CME):

• 4/11/2025 – CME Group had its price target raised by analysts at Oppenheimer Holdings Inc. from $269.00 to $279.00. They now have an “outperform” rating on the stock.
• 4/8/2025 – CME Group had its price target raised by analysts at Piper Sandler from $275.00 to $283.00. They now have an “overweight” rating on the stock.
• 4/8/2025 – CME Group was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $301.00 price target on the stock.
• 4/7/2025 – CME Group had its price target raised by analysts at Barclays PLC from $263.00 to $279.00. They now have an “equal weight” rating on the stock.
• 4/3/2025 – CME Group had its “sector perform” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $269.00 price target on the stock.
• 4/2/2025 – CME Group had its price target raised by analysts at Bank of America Co. from $200.00 to $219.00. They now have an “underperform” rating on the stock.
• 3/17/2025 – CME Group was upgraded by analysts at Erste Group Bank AG to a “strong-buy” rating.
• 3/10/2025 – CME Group was upgraded by analysts at Raymond James from a “market perform” rating to an “outperform” rating. They now have a $287.00 price target on the stock.
• 2/19/2025 – CME Group had its price target raised by analysts at Morgan Stanley from $256.00 to $263.00. They now have an “equal weight” rating on the stock.

CME Group Price Performance

NASDAQ:CME traded up $2.31 during mid-day trading on Thursday, reaching $263.70. The stock had a trading volume of 157,405 shares, compared to its average volume of 2,135,499. The stock has a 50-day simple moving average of $256.36 and a two-hundred day simple moving average of $239.87. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $273.42. The stock has a market capitalization of $95.03 billion, a PE ratio of 27.27, a P/E/G ratio of 6.76 and a beta of 0.43.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. On average, equities analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were paid a $1.25 dividend. This is an increase from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date was Friday, March 7th. This represents a $5.00 annualized dividend and a yield of 1.90%. CME Group’s dividend payout ratio is presently 51.71%.

Insider Buying and Selling at CME Group

In other CME Group news, insider Julie Winkler sold 11,592 shares of CME Group stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the transaction, the insider now directly owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Hilda Harris Piell sold 3,984 shares of the stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now directly owns 27,046 shares of the company’s stock, valued at $6,774,211.62. This represents a 12.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 27,076 shares of company stock worth $6,871,496 over the last quarter. Corporate insiders own 0.30% of the company’s stock.

Institutional Investors Weigh In On CME Group

Several hedge funds and other institutional investors have recently modified their holdings of the company. Ritholtz Wealth Management grew its position in CME Group by 10.3% in the 1st quarter. Ritholtz Wealth Management now owns 4,451 shares of the financial services provider’s stock worth $1,181,000 after purchasing an additional 416 shares in the last quarter. Dynamic Advisor Solutions LLC lifted its holdings in CME Group by 3.1% during the first quarter. Dynamic Advisor Solutions LLC now owns 2,533 shares of the financial services provider’s stock worth $672,000 after acquiring an additional 76 shares during the period. Opal Wealth Advisors LLC purchased a new position in CME Group in the first quarter worth $157,000. Wealth Enhancement Advisory Services LLC grew its stake in CME Group by 63.0% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 105,044 shares of the financial services provider’s stock valued at $27,867,000 after purchasing an additional 40,592 shares during the period. Finally, Stock Yards Bank & Trust Co. purchased a new stake in shares of CME Group during the 1st quarter valued at $210,000. Institutional investors own 87.75% of the company’s stock.

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.